Liver transplantation for intrahepatic cholangiocarcinoma: ready for prime time?
G Sapisochin, T Ivanics, J Heimbach - Hepatology, 2022 - journals.lww.com
Cholangiocarcinoma (CCA) represents the second‐most common primary liver malignancy
after HCC and has risen in incidence globally in the past decades. Intrahepatic …
after HCC and has risen in incidence globally in the past decades. Intrahepatic …
[HTML][HTML] Surgical treatment of intrahepatic cholangiocarcinoma: current and emerging principles
Intrahepatic cholangiocarcinoma (ICC) is a rare, aggressive cancer of the biliary tract. It often
presents with locally advanced or metastatic disease, but for patients with early-stage …
presents with locally advanced or metastatic disease, but for patients with early-stage …
[HTML][HTML] Liver transplantation in the management of cholangiocarcinoma: Evolution and contemporary advances
Cholangiocarcinoma (CCA) is an aggressive malignancy arising from the biliary epithelium.
It may occur at any location along the biliary tree with the perihilar area being the most …
It may occur at any location along the biliary tree with the perihilar area being the most …
[HTML][HTML] Multidisciplinary treatment for hilar and intrahepatic cholangiocarcinoma: A review of the general principles
G Sapisochin, T Ivanics, V Subramanian… - International Journal of …, 2020 - Elsevier
Cholangiocarcinoma (CCA) is a rare but devastating malignancy that presents late, and
associated with a high mortality if untreated. CCA is locally aggressive and located in close …
associated with a high mortality if untreated. CCA is locally aggressive and located in close …
A systematic review and meta‐analysis of pathologic complete response rates for patients with cholangiocarcinoma treated on liver transplant protocols
TC Wu, CP Smith, JS Li, J Burton… - Journal of surgical …, 2024 - Wiley Online Library
Abstract Background and Objectives Many heterogenous orthotopic liver transplant (OLT)
protocols exist for patients with unresectable cholangiocarcinoma. Little is known about the …
protocols exist for patients with unresectable cholangiocarcinoma. Little is known about the …
[HTML][HTML] Incidence trend and competing risk analysis of patients with intrahepatic cholangiocarcinoma: A population-based study
H Xing, B Tan, C Yang, M Zhang - Frontiers in Medicine, 2022 - frontiersin.org
Background: Intrahepatic cholangiocarcinoma (ICCA) is a primary liver cancer characterized
by rapid progression and poor prognosis. There are few effective tools for evaluating the …
by rapid progression and poor prognosis. There are few effective tools for evaluating the …
[HTML][HTML] Stereotactic radiotherapy for intrahepatic cholangiocarcinoma
Intrahepatic cholangiocarcinoma (iCCA) is an aggressive malignancy with an increasing
incidence worldwide and poor prognosis, despite several advances and continuous efforts …
incidence worldwide and poor prognosis, despite several advances and continuous efforts …
[HTML][HTML] Liver transplantation in malignant disease
SA Lang, J Bednarsch, Z Czigany… - World Journal of …, 2021 - ncbi.nlm.nih.gov
Liver transplantation for malignant disease has gained increasing attention as part of
transplant oncology. Following the implementation of the Milan criteria, hepatocellular …
transplant oncology. Following the implementation of the Milan criteria, hepatocellular …
Liver transplantation for cholangiocarcinoma: insights into the prognosis and the evolving indications
GG Panayotova, F Paterno, JV Guarrera… - Current oncology …, 2020 - Springer
Abstract Purpose of Review Cholangiocarcinoma (CCA) is a rare malignancy of the biliary
ducts that can be classified as intrahepatic, perihilar, or distal based on anatomic location …
ducts that can be classified as intrahepatic, perihilar, or distal based on anatomic location …
[HTML][HTML] Cholangiocarcinoma as an indication for liver transplantation in the era of transplant oncology
E Gringeri, M Gambato, G Sapisochin, T Ivanics… - Journal of Clinical …, 2020 - mdpi.com
Cholangiocarcinoma (CCA) arises from the biliary tract epithelium and accounts for 10–15%
of all hepatobiliary malignancies. Depending on anatomic location, CCA is classified as …
of all hepatobiliary malignancies. Depending on anatomic location, CCA is classified as …